Daniele Napolitano
Rome, 00168, Italy
NCT Number: NCT06573619
Objectives of the study are:
* The validation of the GMAS questionnaire in patients with chronic disease. * Measurement of the level of therapeutic adherence in patients with chronic illness. * Measurement of the level of therapeutic adherence in patients with chronic disease undergoing an experimental trial.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Rome, 00168, Italy
The research is multicentre and will be conducted at the Fondazione Policlinico Gemelli IRCCS in Rome as reference centre together with the other participating centres. Patients will be enrolled at the centres involved, either during visits or during their hospital stay.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Validation of questionnaire
Time frame: 1 year
The validation of the GMAS questionnaire in patients with chronic disease.
Time frame: 1 year
Measurement of the level of therapeutic adherence in patients with chronic illness.
Measurement of the level of therapeutic adherence in patients with chronic disease undergoing an experimental trial.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Other
Acronym: GMAS-MCNT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06916247
Chronic Disease, Disease Attributes
Los Angeles, California, United States
View Trial DetailsNCT03195127
Chronic Disease, Critical Illness
Baltimore, Maryland, United States
View Trial DetailsNCT05574699
Cardiovascular Diseases, Chronic Disease
Baltimore, Maryland, United States
View Trial DetailsNCT04264897
Aging, Chronic Disease
Oklahoma City, Oklahoma, United States
View Trial Details